REMICADE®


 
 
 
 
 
 
 
 
 


 

REMICADE® (Infliximab) is an immunosuppressive drug that is used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.

REMICADE® is manufactured by Janssen Biotech.

Administration and Dosage:

Administration of REMICADE® follows an induction regimen of 3 intravenous infusions at week 0, 2, and 6 followed by a maintenance infusion then every 8 weeks for maintenance.

Common Side Effects:

The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.

More Information:

Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.

Indication:

REMICADE® is indicated to treat:

  • Crohn’s Disease
  • Ulcerative Colitis
  • Pediatric Ulcerative Colitis
  • Pediatric Crohn’s Disease
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Plaque Psoriasis